| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2022-02-11 | ORBIMED ADVISORS LLC | Forte Biosciences, Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-02-11 | MORGAN STANLEY | Forte Biosciences, Inc. | 1,111,230 | 7.5% | EDGAR |
| SC 13G | 2022-02-04 | BlackRock Inc. | Forte Biosciences, Inc. | 817,063 | 5.5% | EDGAR |
| SC 13G/A | 2022-02-03 | FRANKLIN RESOURCES INC | Forte Biosciences, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-10-13 | ArrowMark Colorado Holdings LLC | Forte Biosciences, Inc. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2021-09-21 | Oliveira Steven Michael | Forte Biosciences, Inc. | - | 0.0% | EDGAR |
| SC 13D/A | 2021-09-16 | Wagner Paul A. | Forte Biosciences, Inc. | 1,279,049 | 9.1% | EDGAR |
| SC 13G | 2021-09-13 | Logos Global Management LP | Forte Biosciences, Inc. | - | 0.0% | EDGAR |
| SC 13G | 2021-05-18 | Point72 Asset Management, L.P. | Forte Biosciences, Inc. | 695,894 | 5.2% | EDGAR |
| SC 13G/A | 2021-04-12 | ArrowMark Colorado Holdings LLC | Forte Biosciences, Inc. | 1,394,564 | 10.3% | EDGAR |
| SC 13G | 2021-03-22 | PERCEPTIVE ADVISORS LLC | Forte Biosciences, Inc. | 700,000 | 5.2% | EDGAR |
| SC 13G/A | 2021-02-16 | Oliveira Steven Michael | Forte Biosciences, Inc. | 315,000 | 2.5% | EDGAR |
| SC 13G/A | 2021-02-12 | BIOTECHNOLOGY VALUE FUND L P | Forte Biosciences, Inc. | 892,791 | 6.7% | EDGAR |
| SC 13G | 2021-02-12 | ORBIMED ADVISORS LLC | Forte Biosciences, Inc. | 635,766 | 4.7% | EDGAR |
| SC 13G | 2021-02-01 | FRANKLIN RESOURCES INC | Forte Biosciences, Inc. | 1,053,872 | 8.2% | EDGAR |
| SC 13G | 2020-09-01 | Oliveira Steven Michael | Forte Biosciences, Inc. | 225,000 | 2.0% | EDGAR |
| SC 13G/A | 2020-07-10 | BlackRock Inc. | Forte Biosciences, Inc. | 49,441 | 0.5% | EDGAR |
| SC 13G | 2020-07-10 | ArrowMark Colorado Holdings LLC | Forte Biosciences, Inc. | 2,936,708 | 27.2% | EDGAR |
| SC 13D | 2020-06-25 | Wagner Paul A. | Forte Biosciences, Inc. | 2,272,049 | 21.0% | EDGAR |
| SC 13G | 2020-06-25 | BIOTECHNOLOGY VALUE FUND L P | Forte Biosciences, Inc. | 613,299 | 5.6% | EDGAR |